Johnson Dylan M, Woolsey Courtney, Agans Krystle N, Borisevich Viktoriya, Prasad Abhishek N, Deer Daniel J, Dobias Natalie S, Fenton Karla A, Cross Robert W, Geisbert Thomas W
Galveston National Laboratory, University of Texas Medical Branch, Galveston, TX, USA.
Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
EMI Anim Environ. 2025 Jun 11;1(1):2486952. doi: 10.1080/29986990.2025.2486952. eCollection 2025.
Chapare virus (CHAPV) is an emerging New World arenavirus that is the causative agent of Chapare haemorrhagic fever (CHHF) responsible for recent outbreaks with alarmingly high case fatality rates in Bolivia near the Brazilian border. Here, we describe a nonhuman primate (NHP) model of CHHF infection which represents an essential tool to understand this emerging biological threat agent. Cynomolgus macaques challenged intravenously with CHAPV develop clinical disease, which recapitulates several key features of human CHHF. All subjects lost weight and had clinical scores following the CHAPV challenge. Notably, one of four NHPs developed a lethal disease with viral hepatitis and haemorrhagic features. Clinical chemistry and haematology revealed leukopoenia, anaemia, thrombocytopenia, and increased transaminase levels. In all four subjects, viremia was detectable for the first week following the challenge and viral RNA was detectable in serum and many tissues persisting 35 days post-challenge. Several medical countermeasures (MCM) have efficacy against CHAPV infection , but the current model for MCM testing and approval of new drugs is reliant on the availability of animal models. This work lays the foundation for future CHHF MCM development.
查帕雷病毒(CHAPV)是一种新出现的新大陆沙粒病毒,是查帕雷出血热(CHHF)的病原体,该疾病在巴西边境附近的玻利维亚近期爆发,病死率高得惊人。在此,我们描述了一种CHHF感染的非人灵长类动物(NHP)模型,它是了解这种新出现的生物威胁病原体的重要工具。经静脉注射CHAPV攻击的食蟹猴会出现临床疾病,重现了人类CHHF的几个关键特征。所有受试动物在接受CHAPV攻击后体重减轻并出现临床评分。值得注意的是,四只NHP中有一只发展为伴有病毒性肝炎和出血特征的致命疾病。临床化学和血液学检查显示白细胞减少、贫血、血小板减少以及转氨酶水平升高。在所有四只受试动物中,攻击后第一周可检测到病毒血症,攻击后35天血清和许多组织中仍可检测到病毒RNA。几种医学应对措施(MCM)对CHAPV感染有效,但目前MCM测试和新药审批的模型依赖于动物模型的可用性。这项工作为未来CHHF的MCM开发奠定了基础。